<DOC>
	<DOCNO>NCT02232061</DOCNO>
	<brief_summary>This study evaluate patient serious cardiovascular event upon initiation fingolimod risk delevop long term cardiovascular event</brief_summary>
	<brief_title>Long-term , Open-label , Multicenter Study Assessing Long-term Cardiovascular Risks Patients Treated With Fingolimod</brief_title>
	<detailed_description />
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis</mesh_term>
	<mesh_term>Fingolimod Hydrochloride</mesh_term>
	<criteria>Patients participate study FTY720D2406 experience serious cardiovascular event fingolimod treatment initiation Patients still fingolimod first dose serious event</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>multiple sclerosis , fingolimod ,</keyword>
</DOC>